BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Arthur Klausner to be a featured speaker at CED Biotech Forum: Trends in Exit Strategies.
News | 06. 18. 2007
